美国炎症性肠病的发病率、患病率及种族和民族分布
该研究利用4个行政理赔数据集(联邦医疗保险、医疗补助、商业保险)估算美国医生诊断的炎症性肠病(IBD)的发病率、患病率及种族分布。患病率在White人群中为每10万人812,Black人群504,Asian人群403,Hispanic人群458。
要点
- 患病率White人群每10万人812(95%CI 802-823)高于Black人群504、Asian人群403、Hispanic人群458。
核心结论
- 美国超过0.7%的人被诊断为IBD,发病高峰在成年早期后降至较低水平并趋于平稳。
- Black、Asian和Hispanic美国人中IBD诊断较不常见。
研究设计与样本
- 研究使用4个行政理赔数据集:2007至2017年全国按服务收费联邦医疗保险数据20%随机样本;佛罗里达、纽约、宾夕法尼亚、俄亥俄和加利福尼亚州1999至2012年医疗补助数据;Anthem受益人2006至2018年商业健康保险数据;Optum去标识化Clinformatics Data Mart 2000至2017年数据。
- 通过验证的医学诊断、诊断操作和处方药物组合识别新发和现患诊断。
- 计算按年龄、性别和种族/民族分层的保险加权汇总估计值,并标准化至2018年美国人口普查估计值及95%置信区间(CI)。
主要发现
- IBD年龄和性别标化发病率为每10万人年10.9(95%CI 10.6-11.2)。
- IBD年龄、性别和保险标化患病率为每10万人721(95%CI 717-726)。
- IBD患病率每10万人:White人群812(95%CI 802-823),Black人群504(95%CI 482-526),Asian人群403(95%CI 373-433),Hispanic人群458(95%CI 440-476)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: We sought to estimate the incidence, prevalence, and racial-ethnic distribution of physician-diagnosed inflammatory bowel disease (IBD) in the United States. METHODS: The study used 4 administrative claims data sets: a 20% random sample of national fee-for-service Medicare data (2007 to 2017); Medicaid data from Florida, New York, Pennsylvania, Ohio, and California (1999 to 2012); and commercial health insurance data from Anthem beneficiaries (2006 to 2018) and Optum's deidentified Clinformatics Data Mart (2000 to 2017). We used validated combinations of medical diagnoses, diagnostic procedures, and prescription medications to identify incident and prevalent diagnoses. We computed pooled age-, sex-, and race/ethnicity-specific insurance-weighted estimates and pooled estimates standardized to 2018 United States Census estimates with 95% confidence intervals (CIs). RESULTS: The age- and sex-standardized incidence of IBD per 100,000 person-years was 10.9 (95% CI, 10.6-11.2). The incidence of IBD peaked in the third decade of life, decreased to a relatively stable level across the fourth to eighth decades, and declined further. The age-, sex- and insurance-standardized prevalence of IBD was 721 per 100,000 population (95% CI, 717-726). Extrapolated to the 2020 United States Census, an estimated 2.39 million Americans are diagnosed with IBD. The prevalence of IBD per 100,000 population was 812 (95% CI, 802-823) in White, 504 (95% CI, 482-526) in Black, 403 (95% CI, 373-433) in Asian, and 458 (95% CI, 440-476) in Hispanic Americans. CONCLUSIONS: IBD is diagnosed in >0.7% of Americans. The incidence peaks in early adulthood and then plateaus at a lower rate. The disease is less commonly diagnosed in Black, Asian, and Hispanic Americans.
引用
- Lewis JD, Parlett LE, Jonsson Funk ML, et al. Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States. Gastroenterology. 2023. PMID: 37481117. doi:10.1053/j.gastro.2023.07.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。